Research, Select, & Monitor Wednesday, June 03, 2020 9:24:56 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Sanofi vs Drug Delivery

Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.

Innovative companies whose purpose is to design and develop new ways to introduce drugs to the body. These new methods may consist of time-released capsules, differing injection techniques, or enabling certain drugs to be taken orally that may not have been to be taken so before. Their revenue is obtained from selling their technology to pharmaceutical companies or licensing it to manufacturers of prescription drugs.
 Totals Company Industry
  Sales: $42,146.7 Mil $120,115.0 Mil
  Market Cap: $124,854.7 Mil $469,539.3 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
  Historic Revenue: .0% 22.4%
  Estimated Revenue: (.6%) 14.1%
  Historic Earnings: 2.8% 3.3%
  Estimated Earnings: 6.0% (22.8%)
  Stock Price (1 Year): 23.4% (17.0%)
  Cash per Share: 29.3% (3.6%)
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 13.3 18.5
  Price-to-Sales: 3.0 N/A
  Price-to-Book: 1.9 2.3
  Dividend Yield: N/A N/A
  Market Cap: $124,854.7 Mil $36,118.4 Mil
  Net Margin: 21.2% (1,326.0%)
  Gross Margin: 68.2% 61.7%
  Return on Equity: .0 (.0)
  Return on Assets: .0 (2.7)
  Balance Sheet
  Current Ratio: 1.4 2.7
  Quick Ratio: 1.0 2.5
  Cash Ratio: .5 2.0
  Debt-to-Equity: .9 .6
  Interest Coverage: (7.3) (2.4)
  Relative-Strength Index: 61.2 N/A

 Other companies in Drug Delivery Price Market Cap
  Roche Holding AG  (RHHBY) $43.94 $299,963.9 Mil
  Eisai Co Ltd  (ESALY) $80.70 $23,618.8 Mil
  Dr. Reddys Laboratories Ltd.  (RDY) $52.27 $8,693.7 Mil
  Nektar Therapeutics  (NKTR) $22.63 $3,862.6 Mil
  Alkermes, Inc.  (ALKS) $16.68 $2,641.8 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.